Senate 939

WEST virginia legislature

2025 regular session

Originating

Senate Bill 939

By Senators Helton, Deeds, Fuller, Takubo, Weld, and Woelfel

[Originating in the Select Committee on Substance Use Disorder and Mental Health; reported March 27, 2025]

A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §16B-13-4a, relating to testing for substance use disorder; and setting forth testing guidelines for office-based medication-assisted treatment facilities.

Be it enacted by the Legislature of West Virginia:

ARTICLE 13. MEDICATION-ASSISTED TREATMENT PROGRAM LICENSING ACT.

§16B-13-4a. Progression of treatment for substance use disorder.

(a) Upon being admitted as a patient to an office-based medication-assisted treatment program, the provider shall perform a comprehensive, quantitative, direct observation drug test.

(b) After this time and continuing for six weeks, a direct observation, quantitative test must be performed every two weeks for six weeks.

(c) Once the patient moves into the stabilization phase of treatment, the patient shall undergo a direct observation, qualitative test every 45 days for one year while in treatment.

(d) Following the stabilization phase of treatment, the patient moves into the maintenance phase of treatment and during the maintenance phase of treatment shall undergo a direct observation, qualitative test every six months thereafter until discharge from the program.

(e) At any point the provider wants to assess compliance, the patient must be willing to produce a direct observation qualitative or quantitative test upon the provider request.